Skip to main content
. 2011 Jun 13;108(32):E431–E439. doi: 10.1073/pnas.1105876108

Fig. 9.

Fig. 9.

EMSAs using Nla6-DBD and Nla28-DBD as well as the promoter region of the nla6 operon. The assays were performed using an end-labeled nla6 promoter fragment and the following EBP-DBDs: none (lane 1), Nla6-DBD (lane 2), Nla28-DBD (lane 3), and both Nla6-DBD and Nla28-DBD (lane 4).